Beijing: China has put its homegrown coronavirus vaccines on display for the first time. China is the country where the contagion was discovered. Now it looks like the Chinese vaccine may very well give the coronavirus-hit world some relief. The World Health Organisation (WHO) has however, asked people not to pin high hopes on the Chinese vaccine.
High hopes hang on the small vials of liquid on show at a trade fair this week here. They are the vaccine candidates produced by Chinese companies Sinovac Biotech and Sinopharm. Neither has hit the market yet but the makers hope they will be approved after all-important phase 3 trials as early as year-end.
A Sinovac representative said his firm has already ‘completed the construction of a vaccine factory’ able to produce 300 million doses a year. People at the trade fair crowded around booths Monday showing the potential game-changing vaccines.
China, which is facing a storm of foreign criticism over its early handling of the pandemic, has been trying to repurpose the story of COVID-19.
Also read: 3 coronavirus vaccines under testing phase in India: PM Modi
State-run media and government officials are now emphasising the revival of Wuhan, the central Chinese city where the deadly pathogen surfaced, as a success story in the fight against the virus. They are also touting progress on domestic vaccines as a sign of Chinese leadership and resilience in the face of an unprecedented health threat that has pummelled the global economy.
In May, President Xi Jinping pledged to make any potential vaccine developed by China a ‘global public good’.
The potential vaccines on display are among nearly 10 worldwide to enter phase 3 trials. The phase 3 trials are the last step ahead of regulatory approval. Once approved, the countries across the world can stub out the virus and reboot battered economies.
Sinopharm said it anticipates the antibodies from its jab to last between one and three years. However, the final result will only be known after the trials.
China’s nationalistic tabloid ‘Global Times’ reported last month that ‘the price of the vaccines will not be high’. Every two doses should cost below 1,000 yuan ($146), the report said. It quoted Sinopharm’s chairman, who told media he has already been injected with one of the candidate vaccines.
China’s official Xinhua news agency reported another development Monday. It said another vaccine candidate, developed by Chinese military scientists, can deal with mutations in the coronavirus.
As of last month, at least 5.7 billion doses of the vaccines under development around the world had been pre-ordered.